Biodistribution of Zr-89-labeled mAb: physiologic components. (IMAGE)
Caption
(A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and antibody entering tissue interstitium through paracellular pores, and through endothelial cells mediated by neonatal Fc-receptor, leaving tissue by convective transport through lymph flow. (B) Irreversible nonspecific uptake due to mAb degradation in lysosome, followed by residualization of Zr-89. (C) Specific uptake due to target engagement (target binding and internalization of mAb-target antigen).
Credit
Adapted from Lobo et al., J Pharm Sci. (2004;93), and Chen et al., AAPSJ (2012;14).
Usage Restrictions
Please give appropriate credit.
License
Licensed content